Best Practice Considerations by The American Society of Transplant and Cellular Therapy: Infection Prevention and Management After Chimeric Antigen Receptor T Cell Therapy for Hematological Malignancies
Resource type
Journal Article
Authors/contributors
- Shahid, Zainab (Author)
- Jain, Tania (Author)
- Dioverti, Veronica (Author)
- Pennisi, Martina (Author)
- Mikkilineni, Lekha (Author)
- Thiruvengadam, Swetha Kambhampati (Author)
- Shah, Nirali N (Author)
- Dadwal, Sanjeet (Author)
- Papanicolaou, Genovefa (Author)
- Hamadani, Mehdi (Author)
- Carpenter, Paul A. (Author)
- Alfaro, Gabriela Maron (Author)
- Seo, Susan K. (Author)
- Hill, Joshua A. (Author)
Title
Best Practice Considerations by The American Society of Transplant and Cellular Therapy: Infection Prevention and Management After Chimeric Antigen Receptor T Cell Therapy for Hematological Malignancies
Publication
Transplantation and Cellular Therapy
Volume
30
Issue
10
Pages
955-969
Date
10/2024
Journal Abbr
Transplantation and Cellular Therapy
Language
en
ISSN
26666367
Short Title
Best Practice Considerations by The American Society of Transplant and Cellular Therapy
Accessed
6/1/25, 7:45 PM
Library Catalog
DOI.org (Crossref)
Citation
Shahid, Z., Jain, T., Dioverti, V., Pennisi, M., Mikkilineni, L., Thiruvengadam, S. K., Shah, N. N., Dadwal, S., Papanicolaou, G., Hamadani, M., Carpenter, P. A., Alfaro, G. M., Seo, S. K., & Hill, J. A. (2024). Best Practice Considerations by The American Society of Transplant and Cellular Therapy: Infection Prevention and Management After Chimeric Antigen Receptor T Cell Therapy for Hematological Malignancies. Transplantation and Cellular Therapy, 30(10), 955–969. https://doi.org/10.1016/j.jtct.2024.07.018
GUIDELINES
PREVENTION
HEME-ONC AND CELLULAR THERAPIES
Link to this record